KDM5B is a transcription promoter of IGF2BP1, and IGF2BP1 can stabilize KDM5B mRNA to increase KDM5B expression, thus forming a positive feedback loop in HCC. This evidence concerns the gene KDM5B and hepatocellular carcinoma.